The U.S. Securities and Exchange Commission (SEC) has decided to suspend the approval process for settled bitcoin options on the Nasdaq PHLX exchange. This is not just a technical hiccup, but a signal of deep disagreements between key U.S. regulators over the classification of crypto products.
At the center of the conflict is CME Group, which has officially challenged the SEC's decision. The Chicago exchange insists that bitcoin options are a commodity derivative and, therefore, should fall under the exclusive jurisdiction of the Commodity Futures Trading Commission (CFTC), not the SEC. This is a fundamental issue: who will control this instrument will determine not only the fate of a specific product, but also the future regulation of the entire crypto market in the U.S.
Notably, instead of rejecting the application or moving it forward, the SEC has chosen to pause for additional analysis. This is a rare step that points to pressure from CME and potential legal risks. Market participants and interested parties can submit their positions and comments to the SEC until August 24 — this deadline will be key in determining the next trajectory.
For investors, this news means that institutional bitcoin instruments continue to remain hostage to bureaucratic disputes. Approval of Nasdaq options could have significantly boosted liquidity and attracted new players, but now the launch is postponed indefinitely.
My analytical conclusion: This conflict between the SEC and CME is just the tip of the iceberg. We are witnessing a battle for regulatory control over crypto derivatives that will only intensify as the market grows. In the long term, a CME victory could accelerate the adoption of bitcoin as a commodity asset, but in the short term, it could add volatility and uncertainty. Investors should prepare for a prolonged period of regulatory disputes before we see the full launch of such products.